NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

疫苗的全球市場:2027年前的預測 - COVID-19的影響,技術,適應症,給藥途徑,患者類型,各地區的分析

Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology ; Disease Indication ; Route of Administration ; Patient Type and Geography

出版商 The Insight Partners 商品編碼 978925
出版日期 內容資訊 英文 207 Pages
訂單完成後即時交付
價格
疫苗的全球市場:2027年前的預測 - COVID-19的影響,技術,適應症,給藥途徑,患者類型,各地區的分析 Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology ; Disease Indication ; Route of Administration ; Patient Type and Geography
出版日期: 2020年10月19日內容資訊: 英文 207 Pages
簡介

全球疫苗的市場規模在2019年估算為391億2,830萬美金。該市場,在2020年∼2027年間預測將以6.5%的年複合成長率增長,2027年達到645億3,840萬美元。

市場成長的主要因素有傳染病的流行,對疫苗接種計劃的更多關注以及對疫苗開發的更多支持,這將連續長期推動市場成長。還有疫苗的強力開發平台,可以對全球市場的增長產生積極影響。但是,疫苗價格飛漲,疫苗生產的複雜性和成本會阻礙市場的增長。

本報告提供全球疫苗市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,COVID-19疫情的影響,技術·適應症·給藥途徑·患者類型·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 要點

第3章 調查手法

第4章 市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 市場動態

  • 主要市場成長要素
  • 主要的阻礙市場要素
  • 主要市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 市場收益預測與分析
  • 各地區市場預測與分析
  • 主要企業的實際成果

第7章 市場分析:各技術

  • 概要
  • 市場佔有率(2019,2027)
  • 重組疫苗接種疫苗
  • 結合物疫苗
  • 弱毒化疫苗
  • 不活化及次單元疫苗疫苗
  • 類毒素疫苗疫苗

第8章 市場分析:各適應症

  • 概要
  • 市場收益與預測分析
  • Dtp(白喉,破傷風,百日咳)
  • 流感
  • 登革熱
  • 巨細胞病毒(CMV)
  • 肝炎
  • 呼吸道融合瘤病毒(Rsv)
  • 其他

第9章 市場分析:各給藥途徑

  • 概要
  • 市場收益與預測分析
  • 口服
  • 注射
  • 其他

第10章 市場分析:各患者類型

  • 概要
  • 市場收益與預測分析
  • 兒童
  • 成人

第11章 市場分析:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南及中美

第12章 Covid-19疫情的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第13章 產業形勢

  • 概要
  • 市場企業的成長策略
  • 有機開發
  • 無機開發

第14章 企業簡介

  • Pfizer Inc.
  • Glaxosmithkline Plc.
  • Merck & Co., Inc.
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Panacea Biotec Limited
  • Astellas Pharma Inc.
  • Novavax, Inc.
  • Vbi Vaccines Inc.
  • Bavarian Nordic

第15章 附錄

  • The Insight Partners
  • 詞彙表
目錄
Product Code: TIPRE00015468

The vaccines market was valued at US$ 39,128.3 million in 2019 and is projected to reach US$ 64,538.4 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027.The major driving factors are rising prevalence of infectious diseases, growing focus on immunization programs, and increasing support for vaccine development are expected to boost the market growth over the years. However, soaring prices of the vaccines and complexity and cost of vaccine manufacturing are likely to pose a negative impact on the market growth.On the other hand, robust pipeline of vaccines is likely to have a positive impact on the growth of the global vaccines market in the coming years.In the current era, there are increasing concerns of spread of infectious diseases with the changing environment. These emerging infectious diseases are a burden on public health but have also an impact on global economies. The new diseases such as HIV, hepatitis, dengue have attracted a huge concern for the government of the respective countries. There is also resurgence of diseases which seemed to be under control such as malaria, cholera and many more. According to the Centers for Disease control and Prevention in 2015, 16.8 million people in the US visited hospitals due to infectious and parasitic diseases. In Africa, chronic viral hepatitis affects around 70 million Africans (60 million with Hepatitis B and 10 million with Hepatitis C). The disease impacts the most important part of the African population i.e. youths and earning African population which are causing tremendous rise in financial debts incurred for the treatment of advanced liver diseases and emotional distress.Thus the growing global prevalence of infectious diseases are expected to encourage the leading market players for the development of new and effective drugs and vaccines.

The vaccines market by technology is segmented into Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines. In 2019, the conjugate vaccines segment held a largest market share in the vaccines market , By Technology. This segment is also expected to dominate the market in 2027 as they are the most effective forms of immunization, used to prevent diseases in both infants and adults. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 6.3% during the forecast period, 2020 to 2027 owing to the increasing demand for drugs to treat the disease.

The global vaccines market on the patient type is segmented into pediatric patients and adult patients. In 2018, the pediatric segment held a largest market share in the vaccines market , by patient type. This segment is also expected to dominate the market in 2027 as external immunization is necessary for the new borns. Moreover, vaccines have helped the children in staying healthy and been successful to save millions of lives for more than 50 years.

Some of the major primary and secondary sources for vaccines included in the report are World Health Organization (WHO), European Medical Agency (EMA), Advisory Committee on Immunization Practices(ACIP), China Food and Drug Administration (CFDA), Council of Scientific and Industrial Research (CSIR), French Scientific Research Centre (FSRC), and others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope Of The Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Vaccines Market - By Technology
    • 1.3.2 Global Vaccines Market - By Disease Indication
    • 1.3.3 Global Vaccines Market - By Route of Administration
    • 1.3.4 Global Vaccines Market - By Patient Type
    • 1.3.5 Global Vaccines Market - By Geography

2. Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 Pest Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis
  • 4.3 Expert Opinions

5. Global Vaccines Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Infectious Diseases
    • 5.1.2 Growing Focus on Immunization Programs
    • 5.1.3 Increasing Support for Vaccine Development
  • 5.2 Key Market Restraints
    • 5.2.1 The Complexity And Cost of Vaccine Manufacturing
    • 5.2.2 Soaring Costs of Vaccines
  • 5.3 Key Market Opportunities
    • 5.3.1 Robust Pipeline of Vaccines
  • 5.4 Future Trends
    • 5.4.1 New Vaccine Delivery Systems
  • 5.5 Impact Analysis

6. Vaccines Market - Global Analysis

  • 6.1 Global Vaccines Market Revenue Forecasts And Analysis
  • 6.2 Global Vaccines Market, By Geography - Forecasts And Analysis
  • 6.3 Performance Of Key Players
    • 6.3.1 GlaxoSmithKline plc
    • 6.3.2 Sanofi

7. Vaccines Market - Technology

  • 7.1 Overview
  • 7.2 Vaccines Market Share, Technology, 2019 And 2027 (%)
  • 7.3 Recombinant Vaccinesinant Vaccines
    • 7.3.1 Overview
    • 7.3.2 Recombinant Vaccinesinant Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Conjugate Vaccines
    • 7.4.1 Overview
    • 7.4.2 Conjugate Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Live Attenuated Vaccines Attenuated Vaccines
    • 7.5.1 Overview
    • 7.5.2 Live Attenuated Vaccines Attenuated Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Inactivated and Subunit Vaccines Vaccines
    • 7.6.1 Overview
    • 7.6.2 Inactivated and Subunit Vaccines Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Toxoid Vaccines Vaccines
    • 7.7.1 Overview
    • 7.7.2 Toxoid Vaccines Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)

8. Vaccines Market- Disease Indication

  • 8.1 Overview
  • 8.2 Disease Indication Market Revenue And Forecasts Analysis (Us$ Mn)
  • 8.3 Dtp (Diphtheria, Tetanus, And Pertussis)
    • 8.3.1 Overview
    • 8.3.2 DTP (Diphtheria, Tetanus, And Pertussis): Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Influenza
    • 8.4.1 Overview
    • 8.4.2 Influenza: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Dengue
    • 8.5.1 Overview
    • 8.5.2 Dengue: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Cytomegalovirus (CMV)
    • 8.6.1 Overview
    • 8.6.2 Cytomegalovirus (CMV): Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Hepatitis
    • 8.7.1 Overview
    • 8.7.2 Hepatitis: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
    • 8.7.3 Hepatitis A
      • 8.7.3.1 Overview
      • 8.7.3.2 Hepatitis A: Hepatitis Market - Revenue and Forecast to 2027 (US$ Million)
    • 8.7.4 Hepatitis B
      • 8.7.4.1 Overview
      • 8.7.4.2 Hepatitis B: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.8 Respiratory Syncytial Virus (Rsv)
    • 8.8.1 Overview
    • 8.8.2 Respiratory Syncytial Virus (RSV): Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.9 Other Diseases
    • 8.9.1 Overview
    • 8.9.2 Other Diseases: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)

9. Vaccines Market- Route Of Administration

  • 9.1 Overview
  • 9.2 Route Of Administration Market Revenue And Forecasts Analysis (Us$ Mn)
  • 9.3 Oral
    • 9.3.1 Overview
    • 9.3.2 Oral: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Injectable
    • 9.4.1 Overview
    • 9.4.2 Injectable: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Other Routes Of Administrations
    • 9.5.1 Overview
    • 9.5.2 Other Routes of Administration; Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

10. Vaccines Market- Patient Type

  • 10.1 Overview
  • 10.2 Patient Type Market Revenue And Forecasts Analysis (Us$ Mn)
  • 10.3 Paediatric
    • 10.3.1 Overview
    • 10.3.2 Pediatric: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 Adults Market
    • 10.4.1 Overview
    • 10.4.2 Adults: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

11. Vaccines Market- Geographical Analysis

  • 11.1 North America: Vaccines Market
    • 11.1.1 Overview
    • 11.1.2 North America: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
    • 11.1.3 North America: Vaccines Market, By Technology, 2018-2027 (USD Million)
    • 11.1.4 North America: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
      • 11.1.4.1 North America: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
    • 11.1.5 North America: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
    • 11.1.6 North America: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.1.7 North America: Vaccines Market, By Country, 2019 & 2027 (%)
    • 11.1.8 US Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.8.1 US: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.1.8.2 US: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.1.8.2.1 US: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.1.8.3 US: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.1.8.4 US: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.1.9 Canada Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.9.1 Canada: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.1.9.2 Canada: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.1.9.3 Canada: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.1.9.3.1 Canada: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.1.9.4 Canada: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.1.9.5 Canada: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.1.10 Mexico Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.10.1 Mexico: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.1.10.2 Mexico: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.1.10.3 Mexico: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.1.10.3.1 Mexico: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.1.10.4 Mexico: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.1.10.5 Mexico: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
  • 11.2 Europe: Vaccines Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Vaccines Market Revenue, by Country (2019) (US$ Mn)
    • 11.2.3 Europe: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
    • 11.2.4 Europe: Vaccines Market, By Technology, 2018-2027 (USD Million)
    • 11.2.5 Europe: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
      • 11.2.5.1 Europe: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
    • 11.2.6 Europe: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
    • 11.2.7 Europe: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.2.8 Europe: Vaccines Market, By Country, 2019 & 2027 (%)
    • 11.2.9 Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.9.1 Germany: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.2.9.2 Germany: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.2.9.3 Germany: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.2.9.3.1 Germany: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.2.9.4 Germany: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.2.9.5 Germany: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.2.10 UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.10.1 UK: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.2.10.2 UK: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.2.10.3 UK: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.2.10.3.1 UK: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.2.10.4 UK: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.2.10.5 UK: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.2.11 France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.11.1 France: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.2.11.2 France: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.2.11.3 France: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.2.11.3.1 France: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.2.11.4 France: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.2.11.5 France: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.2.12 Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.12.1 Italy: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.2.12.2 Italy: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.2.12.3 Italy: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.2.12.3.1 Italy: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.2.12.4 Italy: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.2.12.5 Italy: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.2.13 Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.13.1 Spain: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.2.13.2 Spain: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.2.13.3 Spain: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.2.13.3.1 Spain: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.2.13.4 Spain: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.2.13.5 Spain: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
  • 11.3 Asia Pacific Vaccines Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
    • 11.3.3 Asia Pacific: Vaccines Market, By Technology, 2018-2027 (USD Million)
    • 11.3.4 Asia Pacific: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
      • 11.3.4.1 Asia Pacific: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
    • 11.3.5 Asia Pacific: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
    • 11.3.6 Asia Pacific: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.3.7 Asia Pacific: Vaccines Market, By Country, 2018 & 2027 (%)
    • 11.3.8 China Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.8.1 China: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.3.8.2 China: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.3.8.3 China: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.3.8.3.1 China: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.3.8.4 China: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.3.8.5 China: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.3.9 Japan Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.9.1 Japan: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.3.9.2 Japan: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.3.9.3 Japan: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.3.9.3.1 Japan: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.3.9.4 Japan: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.3.9.5 Japan: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.3.10 India Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.10.1 India: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.3.10.2 India: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.3.10.3 India: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.3.10.3.1 India: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.3.10.4 India: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.3.10.5 India: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.3.11 Australia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.11.1 Australia: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.3.11.2 Australia: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.3.11.3 Australia: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.3.11.3.1 Australia: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.3.11.4 Australia: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.3.11.5 Australia: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.3.12 South Korea Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.12.1 South Korea: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.3.12.2 South Korea: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.3.12.3 South Korea: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.3.12.3.1 South Korea: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.3.12.4 South Korea: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.3.12.5 South Korea: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
  • 11.4 Middle East & Africa Vaccines Market
    • 11.4.1 Middle East And Africa: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
    • 11.4.2 Middle East and Africa: Vaccines Market, By Technology, 2018-2027 (USD Million)
    • 11.4.3 Middle East and Africa: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
      • 11.4.3.1 Middle East and Africa: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
    • 11.4.4 Middle East and Africa: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
    • 11.4.5 Middle East and Africa: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.4.6 Middle East & Africa: Vaccines Market, By Country, 2019 & 2027 (%)
    • 11.4.7 UAE Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.7.1 UAE: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.4.7.2 UAE: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.4.7.3 UAE: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.4.7.3.1 UAE: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.4.7.4 UAE: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.4.7.5 UAE: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.4.8 Saudi Arabia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.8.1 Saudi Arabia: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.4.8.2 Saudi Arabia: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.4.8.3 Saudi Arabia: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.4.8.3.1 Saudi Arabia: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.4.8.4 Saudi Arabia: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.4.8.5 Saudi Arabia: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.4.9 South Africa Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.9.1 South Africa: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.4.9.2 South Africa: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.4.9.3 South Africa: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.4.9.3.1 South Africa: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.4.9.4 South Africa: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.4.9.5 South Africa: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
  • 11.5 South And Central America Vaccines Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
    • 11.5.3 South and Central America: Vaccines Market, By Technology, 2018-2027 (USD Million)
    • 11.5.4 South and Central America: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
      • 11.5.4.1 South and Central America: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
    • 11.5.5 South and Central America: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
    • 11.5.6 South and Central America: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.5.7 South and Central America: Vaccines Market, by Country, 2019 and 2027 (%)
    • 11.5.8 Brazil Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.5.8.1 Brazil: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.5.8.2 Brazil: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.5.8.3 Brazil: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.5.8.3.1 Brazil: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.5.8.4 Brazil: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.5.8.5 Brazil: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
    • 11.5.9 Argentina Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.5.9.1 Argentina: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
      • 11.5.9.2 Argentina: Vaccines Market, By Technology, 2018-2027 (USD Million)
      • 11.5.9.3 Argentina: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
        • 11.5.9.3.1 Argentina: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
      • 11.5.9.4 Argentina: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
      • 11.5.9.5 Argentina: Vaccines Market, By Patient Type, 2018-2027 (USD Million)

12. Impact Of Covid-19 Pandemic On Global Vaccines Market

  • 12.1 North America: Impact assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
  • 12.4 Rest of World: Impact assessment of COVID-19 Pandemic

13. Vaccines Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done By The Companies In The Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Vaccines Market -Key Company Profiles

  • 14.1 Pfizer Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Financial Overview
    • 14.1.4 Product Portfolio
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Glaxosmithkline Plc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Financial Overview
    • 14.2.4 Product Portfolio
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Merck & Co., Inc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Financial Overview
    • 14.3.4 Product Portfolio
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sanofi
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Financial Information
    • 14.4.4 Product Portfolio
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Johnson & Johnson Services, Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Financial Overview
    • 14.5.4 Product Portfolio
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Panacea Biotec Limited
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Financial Information
    • 14.6.4 Product Portfolio
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Astellas Pharma Inc.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Financial Overview
    • 14.7.4 Product Portfolio
    • 14.7.5 Swot Analysis
    • 14.7.6 Key Developments
  • 14.8 Novavax, Inc.
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Financial Information
    • 14.8.4 Product Pipeline
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Vbi Vaccines Inc.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Financial Information
    • 14.9.4 Product Portfolio
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Bavarian Nordic
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Financial Information
    • 14.10.4 Product Pipeline
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary Of Terms

List Of Tables

  • Table 1. North America Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 2. North America: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 3. North America: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 4. North America: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 5. North America: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 6. US Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 7. US: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 8. US: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 9. US: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 10. US: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 11. Canada Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 12. Canada: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 13. Canada: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 14. Canada: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 15. Canada: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 16. Mexico Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 17. Mexico: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 18. Mexico: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 19. Mexico: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 20. Mexico: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 21. Europe Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 22. Europe: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 23. Europe: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 24. Europe: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 25. Europe: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 26. Germany Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 27. Germany: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 28. Germany: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 29. Germany: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 30. Germany: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 31. UK Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 32. UK: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 33. UK: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 34. UK: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 35. UK: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 36. France Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 37. France: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 38. France: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 39. France: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 40. France: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 41. Italy Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 42. Italy: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 43. Italy: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 44. Italy: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 45. Italy: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 46. Spain Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 47. Spain: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 48. Spain: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 49. Spain: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 50. Spain: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 51. Asia Pacific Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 52. Asia Pacific: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 53. Asia Pacific: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 54. Asia Pacific: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 55. Asia Pacific: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 56. China Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 57. China: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 58. China: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 59. China: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 60. China: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 61. Japan Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 62. Japan: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 63. Japan: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 64. Japan: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 65. Japan: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 66. India Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 67. India: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 68. India: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 69. India: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 70. India: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 71. Australia Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 72. Australia: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 73. Australia: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 74. Australia: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 75. Australia: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 76. South Korea Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 77. South Korea: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 78. South Korea: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 79. South Korea: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 80. South Korea: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 81. Middle East and Africa Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 82. Middle East and Africa: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 83. Middle East and Africa: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 84. Middle East and Africa: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 85. Middle East and Africa: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 86. UAE Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 87. UAE: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 88. UAE: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 89. UAE: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 90. UAE: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 91. Saudi Arabia Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 92. Saudi Arabia: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 93. Saudi Arabia: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 94. Saudi Arabia: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 95. Saudi Arabia: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 96. South Africa Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 97. South Africa: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 98. South Africa: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 99. South Africa: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 100. South Africa: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 101. South and Central America Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 102. South and Central America: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 103. South and Central America: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 104. South and Central America: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 105. South and Central America: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 106. Brazil Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 107. Brazil: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 108. Brazil: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 109. Brazil: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 110. Brazil: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 111. Argentina Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
  • Table 112. Argentina: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
  • Table 113. Argentina: Vaccines Market, By Hepatitis- Revenue And Forecasts to 2027 (USD Million)
  • Table 114. Argentina: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
  • Table 115. Argentina: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
  • Table 116. Organic Developments Done By Companies
  • Table 117. Inorganic developments done by Companies
  • Table 118. Glossary of Terms, vaccines market

List Of Figures

  • Figure 1. Vaccines Market Segmentation
  • Figure 2. Vaccines Segmentation, By Region
  • Figure 3. Vaccines Market Overview
  • Figure 4. Conjugate VAccines technology Segment Held Largest Share of vaccines Market
  • Figure 5. APAC to Show Significant Growth During Forecast Period
  • Figure 6. Vaccines Market, by Geography (US$ Million)
  • Figure 7. Global Vaccines Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Vaccines Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South and central america PEST Analysis
  • Figure 14. vaccines market impact analysis of driver and restraints
  • Figure 15. global Vaccines market - Revenue Forecasts and Analysis -2019- 2027
  • Figure 16. global Vaccines market - by geography Forecasts and Analysis - 2019- 2027
  • Figure 17. Vaccines Market Share, Technology, 2019 and 2027 (%)
  • Figure 18. Recombinant Vaccinesinant Vaccines: Vaccines Market- Revenue And Forecasts To 2027 (US$ Million)
  • Figure 19. Conjugate Vaccines: Vaccines Market- Revenue And Forecasts To 2027 (US$ Million)
  • Figure 20. Live Attenuated Vaccines Attenuated Vaccines: Vaccines Market - Revenue And Forecasts To 2027 (US$ Million)
  • Figure 21. Inactivated and Subunit Vaccines Vaccines: Vaccines Market- Revenue And Forecasts to 2027 (US$ Million)
  • Figure 22. Toxoid Vaccines Vaccines: Vaccines Market- Revenue And Forecasts To 2027 (US$ Million)
  • Figure 23. Disease Indication MARKET Analysis and Forecasts 2019 and 2027 (%)
  • Figure 24. DTP (Diphtheria, Tetanus, And Pertussis): Vaccines Market- Revenue And Forecasts To 2027 (US$ Million)
  • Figure 25. Influenza: Vaccines Market- Revenue And Forecasts to 2027 (US$ Million)
  • Figure 26. Dengue: Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 27. Cytomegalovirus (CMV): Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 28. Hepatitis: Vaccines Market - Revenue And Forecasts To 2027 (US$ Million)
  • Figure 29. Hepatitis A: Hepatitis Market -Revenue And Forecasts To 2027 (US$ Million)
  • Figure 30. Hepatitis B: Vaccines Market -Revenue And Forecasts to 2027 (US$ Million)
  • Figure 31. Respiratory Syncytial Virus (RSV): Vaccines Market - Revenue And Forecasts To 2027 (US$ Million)
  • Figure 32. Other Diseases: Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 33. route of administration MARKET Analysis and Forecasts 2019 and 2027 (%)
  • Figure 34. Oral: Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 35. Injectable: Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 36. Other Routes Of Administration: Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 37. patient type MARKET Analysis and Forecasts 2019 and 2027 (%)
  • Figure 38. Pediatric: Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 39. Adults: Vaccines Market - Revenue And Forecasts to 2027 (US$ Million)
  • Figure 40. North America: Vaccines Market, By Country (2019) (usD Million)
  • Figure 41. North America Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 42. North America: Vaccines Market, By Country, 2019& 2027 (%)
  • Figure 43. US Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 44. Canada Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 45. Mexico Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 46. Europe Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 47. Europe: Vaccines Market, By Country, 2019 & 2027 (%)
  • Figure 48. Germany Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 49. UK Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 50. France Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 51. Italy Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 52. Spain Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 53. Asia Pacific Vaccines market revenue Overview, by Country (2019) (us $ mn)
  • Figure 54. Asia Pacific Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 55. Asia Pacific: Vaccines Market, By Country, 2018 & 2027 (%)
  • Figure 56. China Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 57. Japan Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 58. India Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 59. Australia Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 60. South Korea Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 61. Middle East & Africa Vaccines market REVENUE, by Country, 2019 (US$ MN)
  • Figure 62. Middle East and Africa Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 63. Middle East & Africa: Vaccines Market, By Country, 2019 & 2027 (%)
  • Figure 64. UAE Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 65. Saudi Arabia Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 66. South Africa Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 67. South and Central America Vaccines market REVENUE, by Country, 2019 (US$ MN)
  • Figure 68. South and Central America Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 69. South and Central America: Vaccines Market, by Country, 2019 and 2027 (%)
  • Figure 70. Brazil Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 71. Argentina Vaccine Market Revenue And Forecasts to 2027 (US$ Million)
  • Figure 72. Impact of COVID-19 Pandemic Vaccines Market in North American Countries
  • Figure 73. Impact of COVID-19 Pandemic Vaccines Market in European Countries
  • Figure 74. Impact of COVID-19 Pandemic Vaccines Market in Asia Pacific Countries
  • Figure 75. Impact of COVID-19 Pandemic Vaccines Market in Rest of World Countries
  • Figure 76. Growth Strategies done by the companies in the Market, (%)